ISSN : 2153-2435

Pharmaceutica Analytica Acta
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
Farid Menaa
Farid Menaa Dr.Farid Menaa
Department of Nanomedicine, Oncology and Stem Cells Fluorotronics, Inc
San Diego, California

Dr. Farid Menaa (Bsc. Eng., Bsc. Bio., Msc. Genetics, Master Gerontology/Geriatry, PhD Radiation Oncology and Gerontology, EMBA Entrepreneurship and MD candidate), is an inter- and multi-disciplinary professional. Professor, Principal Investigator, Director, Consultant Editor, Reviewer, Event Organizer and Entrepreneur, Dr. Menaa earned his degrees with highest distinctions from prestigious French universities and institutions. Dr. Menaa followed a post-doctoral in Oncology as a NIH-fellow (San Diego, California, USA; 2004-2007). Subsequently, Dr. Menaa pursed his career in Dermatology, and Stem Cells as a DFG-Fellow (Wuerzburg, Germany; 2007–2009). Then, Dr. Menaa was promoted as Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. (CA, USA; 2009-2010), a nanotechnology and fluorine chemical company. Eventually, Dr. Menaa was appointed Principal Investigator in Hematology and Genomics as a FAPESP-Fellow (São Paulo, Brazil; 2010–2012). During his career, Dr. Menaa also followed complementary formations (e.g. Medecine, Pharmacy, Biochemistry, Biophysics, Food Sciences and Technology, Marine Biology, Nano-Biotechnology, Bio-Computation, Bio-Statistics, Business Development and Management, Technological Innovation and Quality). Overall, Dr. Menaa was involved in various R&D projects in multiple areas of medicine/nanomedicine, pharmacy/pharmacology/toxicology, biology, stem cells/tissue engineering, genetics/genomics, fluorine chemistry/biochemistry, biophysics/biophotonics, food science, technology/nanotechnology, and business). His main current focuses are related to preventive, personalized, translational, integrative and nanomedicine, especially in the areas of oncology, regenerative medicine and gerontology, in order to prevent and implement early diagnosis and efficient therapy. Dr. Menaa has a strong experience with teaching, research and development, supervision, edition, leadership, coaching, consulting, event organizations, scientific & medical collaborations in several countries. Dr. Menaa is, among others, the leading organizer of the Target Meeting´s 1st World Nanomedicine and Nanobiotechnology Online Conference 2013 (, co-organizer of “Nanomaterials Conference” 2013 (Beijing, China) and 2014 (Shenzhen, China), member of the technical committee of the “3rd ScienceOne Conference on Drug Discovery and Development” 2014 (Dubai, UAE). Dr. Menaa is a member of several prestigious organizations (medical and scientific societies), editor, guest editor and reviewer of a large number of esteemed journals worldwide (>50) (e.g. Current Medicinal Chemistry, International Journal of Nanomedicine, Current Organic Chemistry). Among them, he sits on the prestigious editorial boards of Current Drug Therapy (for which is also the lead guest editor of a special issue on nano-pharmaceuticals), Journal of Nanomaterials & Molecular Nanotechnology (JNMN) (for which he is also a guest editor of a special issue on graphene), Journal of Biomaterials and Nanobiotechnology (JBNB), and Journal of Nanomedicine and Biotherapeutics Discovery (JNBD). Dr. Menaa authored and co-authored more than 100 publications (including peer-reviewed ISI research and review articles, books, book chapters, conference proceedings, patents). Dr. Menaa is often invited as a speaker, keynote/featured speaker and (co-)chairman to reputed world congresses and institutions, where he is offering speeches in various areas of medicine, sciences and technology. During his spare time, Dr. Menaa enjoys family, arts, sports and travelling

Research Interest

  The main current focuses are related to preventive, personalized, translational, integrative and nanomedicine, especially in the areas of oncology, regenerative medicine and gerontology, in order to prevent and implement early diagnosis and efficient therapy.


Global Speakers in the subject

Global Experts in the subject


Curcumin Nano-Sized Delivery Systems against Cancers: From Bench to Clinics

Farid Menaa

Editorial: J Pharma Care Health Sys 2015, 2: e135
doi: 10.4172/2376-0419.1000e135
Tapping into Deep-Water Reservoirs to Overcome Antibiotic Resistance through Bacteria-Producing Unique Secondary Metabolites

Farid Menaa

Editorial: Pharm Anal Acta 2015, 6: e172
doi: 10.4172/2153-2435.1000e172
Skin Anti-Aging Benefits of Phytotherapeutics-based Emulsions

Farid Menaa

Editorial: Pharm Anal Acta 2014, 5: e168
doi: 10.4172/2153-2435.1000e168
Supplementation of Vitamin D in Patients with Sickle Cell Bone Disease: A Dbate or a Combate?

Farid Menaa

Editorial: J Hematol Thrombo Dis 2014, 2:e115
doi: 10.4172/2329-8790.1000e115
Financial Governance in the Nanotechnology Segment: The Brazilian Experience

Farid Menaa

Editorial: J Bus Fin Aff 2014, 3:e144
doi: 10.4172/2167-0234.1000e144
Emulsions Systems for Skin Care: From Macro to Nano-Formulations

Farid Menaa

Editorial: J Pharma Care Health Sys 2014, 1: e104
doi: 10.4172/jpchs.1000e104
Development and Optimization of Dimethicone-based Cream Containing Muscat Hamburg Grape Extract: In-vitro Evaluation

Arfa Sharif, Naveed Akhtar, Muhammad Shoaib Khan, Bouzid Menaa, Barkat Ali Khan and Farid Menaa

Research Article: J Pharma Care Health Sys 2014, 1: 1
Policy Implications for Global Pervasive Nanotechnology Innovation

Farid Menaa

Editorial: Pharm Anal Acta 2014, 5: e162
doi: 10.4172/2153-2435.1000e162
Graphene-Based Biosensors for Nano and Pico Applications: The Future is here!

Farid Menaa

Editorial: Pharm Anal Acta 2014, 5: e161
doi: 10.4172/2153-2435.1000e161
Global Financial Model for Responsible Research and Development of the Fast Growing Nanotechnology Business

Farid Menaa

Editorial: J Bus Fin Aff 2014, 3:e139
Functional Graphene-Based Nanobioimaging Platforms: New Powered Real-Time Interfaces

Farid Menaa

Editorial: J Mol Imaging Dynam 2013, 3:e103
doi: 10.4172/2155-9937.1000e103
Importance of Fluorine and Fluorocarbons in Medicinal Chemistry and Oncology

Farid Menaa, Bouzid Menaa and Olga N Sharts

Review Article: J Mol Pharm Org Process Res 2013, 1:104
doi: 10.4172/2329-9053.1000104
Physical Characterization of Blood Substitutes by Carbon-Fluorine Spectroscopy

Farid Menaa, Bouzid Menaa, Partha P Kundu, Chandrabhas Narayana and Olga N Sharts

Research Article: Pharmaceut Anal Acta 2013; 4: 235
doi: 10.4172/2153-2435.1000235
When Pharma Meets Nano or The Emerging Era of Nano-Pharmaceuticals

Farid Menaa

Short Communication: Pharmaceut Anal Acta 2013; 4: 223
doi: 10.4172/2153-2435.1000223

türk porno izletürk pornoları doyasıya izleyin ve boşalın.

OMICS International Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
OMICS International Conferences 2016-17
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version